An interventional study of lactase administration and placebo in Premature, Feeding Disorders and Lactase Deficiency, Congenital, sponsored by Alexandria University. Recruiting at 1 site in Egypt. Open to participants aged 3 Days to 1 Month. Per ClinicalTrials.gov, last updated 2026-01-16.
Sponsored by Alexandria University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 10 studies in Premature Birth by Alexandria University — 5 open to participants now, 5 under way, none of them phase 3. Premature Birth · Alexandria University.
Among the 10 studies in Premature Birth by Alexandria University, this one is the 3rd largest by planned enrollment, is one of 2 that started in 2025, is one of 8 with no phase, and was the 9th registered.
2,557 studies on the registry are indexed under Premature Birth; 504 are open to participants now.
Browse Premature Birth studies →5 of the 10 studies in Premature Birth by Alexandria University are open now, in 1 country. Recruiting first, the newest first:
Alexandria University · Sites in Egypt
Ages 1 min–2 min · Healthy volunteers
Alexandria University · Sites in Egypt
Ages 1 hrs–24 hrs · Healthy volunteers
Alexandria University · Sites in Egypt
Ages 1 hrs–3 days
Alexandria University
Ages 5 min–6 hrs
By country, each count listing its studies:
Of the 318 Premature Birth studies recruiting now, 88 (28%) set no upper age limit and 226 (71%) stop at 75 or younger; 243 take children under 18; 104 take healthy volunteers.
This study: 3 Days to 1 Month · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
10 studies; the count open now beside each. This study's row is marked.
First in 2021; this study’s year is marked. 2 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 120 is above the median of 84 across 1,670 interventional studies indexed under Premature Birth.
Median enrollment 100 across the 10 interventional studies. Of the 5 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
Alexandria University is the lead sponsor of 610 studies on the registry; 143 are open to participants now.
Of its 13 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
1 of the studies in Premature Birth by Alexandria University that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07896824Alexandria UniversityThe Hemodynamic Impact of High-frequency Oscillatory Ventilation and Periodic Sighs in Preterm Infants | 2027-11-15 |
Add it to your calendar (.ics) → With an account.
Among the 10 studies in Premature Birth by Alexandria University, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This study aims to study the effect of lactase enzyme in preventing feeding intolerance in preterm neonates in neonatal intensive care unit at Alexandria University Children's Hospital.
Inclusion criteria will be as follows:
Patients with any of the following will be excluded:
Drug: lactase administration
Other: placebo
1 drop for each 10 ml of formula milk for 14 days
10 ml milk without lactase
Feeding intolerance:
vomiting number per day aspirates in ml/day abdominal distension by measuring abdominal circumference before and after feeds
Time frame: first two weeks of life
Plan to share: Undecided
No publications or documents are linked to this record.
Started Aug 2025 (actual). Primary completion is estimated for Feb 2026, 5 months after the start.
Of 746 non-industry interventional studies with no phase under Premature Birth, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 47. This study's planned 5 months is below that.
Counting every sponsor, half of 764 studies reached it within 24 months; a quarter within 12 and three quarters within 47.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.